Barnes Alane P

Average Profitability
118.24%
Insider Buys Quantity
2
Insider Buys Sum
$85,650.00
Insider Sells Quantity
8
Insider Sells Sum
$4.77M

Insider Activity of Barnes Alane P

According to the SEC Form 4 filings, Barnes Alane P, being in a position of

  1. Chief Legal Officer at BioCryst Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 5000 shares for $27,650, and sold 0 shares,
    over all time since 2014-03-04, has bought 45000 shares for $85,650, and sold 457461 share for $4.77M.

The largest purchase of all time was on 2019-11-18 and amounted to 40000 shares of BioCryst Pharmaceuticals, Inc. for $58,000.

The largest sale of all time was on 2021-05-11 and amounted to 205560 shares of BioCryst Pharmaceuticals, Inc. for $2.47M.

Biography of Barnes Alane P

No biography is available at this moment.

2024-05-13PurchaseBioCryst Pharmaceuticals, Inc.
BCRX
Chief Legal Officer
5,000
0.0024%
$5.53$27,650+32.09%
2022-12-15SaleBioCryst Pharmaceuticals, Inc.
BCRX
Chief Legal Officer
4,175
0.0023%
$10.88$45,424-30.48%
2021-05-11SaleBioCryst Pharmaceuticals, Inc.
BCRX
Chief Legal Officer
205,560
0.1145%
$12.04$2.47M+25.29%
2020-12-11SaleBioCryst Pharmaceuticals, Inc.
BCRX
Senior VP, Chief Legal Officer
27,482
0.0123%
$6.05$166,404+59.98%
2020-12-04SaleBioCryst Pharmaceuticals, Inc.
BCRX
Senior VP, Chief Legal Officer
27,482
0.0084%
$3.12$85,606+112.95%
2019-11-18PurchaseBioCryst Pharmaceuticals, Inc.
BCRX
Senior VP, Chief Legal Officer
40,000
0.026%
$1.45$58,000+118.24%
2018-11-30SaleBioCryst Pharmaceuticals, Inc.
BCRX
Senior VP, Chief Legal Officer
88,580
0.0797%
$9.07$803,421-60.51%
2016-09-14SaleBioCryst Pharmaceuticals, Inc.
BCRX
VP, General Counsel & Corp Sec
16,714
0.0227%
$4.27$71,369+33.1%
2015-06-19SaleBioCryst Pharmaceuticals, Inc.
BCRX
VP, General Counsel & Corp Sec
6,000
0.0079%
$15.00$90,000-41.64%
2014-03-04SaleBioCryst Pharmaceuticals, Inc.
BCRX
VP, General Counsel & Corp Sec
81,468
0.1354%
$12.63$1.03M-13.22%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.